259
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome

, , , , &
Pages 2339-2348 | Published online: 10 Sep 2015

References

  • AndreasenNCCarpenterWTJrKaneJMLasserRAMarderSRWeinbergerDRRemission in schizophrenia: proposed criteria and rationale for consensusAm J Psychiatry2005162344144915741458
  • BarakYAizenbergDClinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatmentBMC Psychiatry20121210822882755
  • BestMWGuptaMBowieCRHarveyPDA longitudinal examination of the moderating effects of symptoms on the relationship between functional competence and real world functional performance in SchizophreniaSchizopr Res Cogn2014129095
  • SanLCiudadAAlvarezEBobesJGilataberteISymptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional studyEur Psychiatry200722849049817904337
  • ShrivastavaAJohnstonMShahNBureauYRedefining outcome measures in schizophrenia: integrating social and clinical parametersCurr Opin Psychiatry201023212012620057314
  • BaiYMHsiaoCYChenKCThe development of a self-reported scale for measuring functionality in patients with schizophrenia – self-reported version of the graphic Personal and Social Performance (SRG-PSP) scaleSchizopr Res20141592–3546551
  • DavidsonLSchnmutteTDinzeoTAndres-HymanRRemission and recovery in schizophrenia: practitioner and patient perspectivesSchizopr Bull200834158
  • HarveyPDStrassnigMPredicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health statusWorld Psychiatry2012112737922654932
  • KarowAMoritzSLambertMSchöttleDNaberDEGOFORS InitiativeRemitted but still impaired? Symptomatic versus functional remission in patients with schizophreniaEur Psychiatry20122740140521570262
  • LibermanRPKopelowiczARecovery from schizophrenia: a concept in search of researchPsychiatr Serv200556673574215939952
  • UstunBKennedyCWhat is “functional impairment”? Disentangling disability from clinical significanceWorld Psychiatry200982828519516924
  • van OsJBurnsTCavallaroRLeuchtSStandardized remission criteria in SchizophreniaActa Psychiatr Scand20061132919516423159
  • EmsleyRChilizaBAsmalLLehloenyaKThe concepts of remission and recovery in schizophreniaCurr Opin Psychiatry201124211412121285703
  • BrissosSDiasVVBalanzá-MartinezVCaritaAIFigueiraMLSymptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performanceSchizophr Res20111292–313313621514793
  • WeidenPZygmuntAMedication noncompliance in schizophrenia: part I. AssessmentJournal of Practical Psychiatry and Behavioral Health19973106110
  • BurnsTEvolution of outcome measures in schizophreniaBr J Psychiatry200750s1s6
  • YanosPTMoosHDeterminants of functioning and well-being among individuals with schizophrenia: an integrated modelClin Psychiatr Rev20072715877
  • GorwoodPPeuskensJEuropean Group On Functional Outcomes, Remission in SchizophreniaSetting new standards in schizophrenia outcomes: symptomatic remission 3 years before versus after the Andreasen criteriaEur Psychiatry201227317017521641777
  • LeuchtSLasserRThe concepts of remission and recovery in schizophreniaPharmacopsychiatry200639516117016944406
  • LlorcaPMSacchettiELloydKKisslingWMedoriRLong-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 monthsInt J Clin Pharmacol Ther2008461142218218293
  • HenryLPAmmingerGPHarrisMGThe EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admissionJ Clin Psychiatry201071671672820573330
  • YeomansDTaylorMCurriAResolution and remission in schizophrenia: getting well and staying wellAdv Psychiatr Treat20101628689
  • AlAqeelBMargoleseHRemission in schizophrenia: critical and systematic reviewHarv Rev Psychiatr2012206281297
  • RemingtonGKapurSRemission: what’s in a name?Am J Psychiatry2005162122393239416330612
  • KuriharaTKatoMRevergerRTirtaGRRemission in schizophrenia: a community-based 6-year follow-up study in BaliPsychiatr Clin Neurosci2011655472482
  • NasrallahHATargumSDTandonRMcCombsSRossRDefining and measuring clinical effectiveness in the treatment of schizophreniaPsychiatr Serv200556327328215746501
  • BarakYBleichAAizenbergDPsychosocial remission in schizophrenia: developing a clinician-rated scaleCompr Psychiatry2010511949819932832
  • PeuskensJGorwoodPEGOFORS InitiativeHow are we assessing functioning in schizophrenia? A need for a consensus approachEur Psychiatry201227639139521632218
  • KeefeRSPoeMWalkerTMHarveyPDThe relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcomeJ Clin Exp Neuropsychol200628226026916484097
  • FigueiraMBrissosSMeasuring psychosocial outcomes in schizophrenia patientsCurr Opin Psychiatry2011242919921285701
  • TseSDavidsonLChungKFYuCHNgKLTsoiELogistic regression analysis of psychosocial correlates associated with recovery from schizophrenia in a Chinese communityInt J Soc Psychiatry2015611505724869851
  • ViertiöSTuulio-HenrikssonAPeräläJActivities of daily living, social functioning and their determinants in persons with psychotic disorderEur Psychiatry201227640941521377336
  • LambertMKarowALeuchtSSchimmelmannBGNaberDRemission in schizophrenia: validity, frequency, predictors, and patients’ perspective 5 years laterDialogues Clin Neurosci201012339340720954433
  • LeifkerFRPattersonTLHeatonRKHarveyPDValidating measures of real-world outcome: the results of the VALERO expert survey and RAND panelSchizophr Bull201137233434319525354
  • MueserKTarrierNPrefaceHandbook of Social Functioning in SchizophreniaBoston, MAAlly and Bacon1998XIIII
  • BellackASGreenMFCookJAAssessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshopSchizophr Bull200733380582216931542
  • AlbertNBertelsenMThorupAPredictors of recovery from psychosis Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 yearsSchizophr Res20111252–325726621056926
  • CannavóDConcertoCBattagliaEInsight and recovery in schizophrenic patients: an observational studyClin Neuropsychop-harmacology2013231S83S84
  • CiudadABobesJAlvarezESanLNovickDGilaberteIClinical meaningful outcomes in schizophrenia: remission and recoveryRev Psiquiatr Salud Ment2011415365 English and Spanish23446102
  • ValenciaMCaraveoJColínRVerduzcoWCoronaFSymptomatic remission and recovery in patients with schizophreniaSalud Mental J20143715974
  • BobesJCiudadAAlvarezESanLPolaviejaPGilaberteIRecovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remissionSchizophr Res20091151586619729283
  • CohenCIPathakRRamirezPMVahiaIOutcome among community dwelling older adults with schizophrenia: results using five conceptual modelsCommunity Ment Health J200945215115818787951
  • Schennach-WolffRJägerMSeemüllerFDefining and predicting functional outcome in schizophrenia and schizophrenia spectrum disordersSchizophr Res20091132–321021719560901
  • LambertMDe MarinisTPfeilJNaberDSchereinerAEstablishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatmentEur Psychiatry200925422022919926263
  • GuyWClinical global impressionsECDEU Assessment Manual for Psychopharmacology: Revised 1976Rockville, MDNational Institute of Mental Health1976217222
  • MurphyHBRamanACThe chronicity of schizophrenia in indigenous tropical peoples. Results of a twelve-year follow-up survey in MauritiusBr J Psychiatry19711185464894975103959
  • RossiABagalàADel CuratoloVScapatiFBernareggiMMGiustraMGRisperidone Long-Acting Trial Investigators (R-LAI)Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorderHum Psychopharmacol200924757458319790173
  • LiCTSuTPChouYHSymptomatic resolution among Chinese patients with schizophrenia and associated factorsJ Formos Med Assoc2010109537838820497871
  • SaravananBJacobKSJohnsonSPrinceMBhugraDDavidASOutcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathologyBr J Psychiatry2010196645445920513855
  • MosolovSNPotapovAVUshakovUVShafarenkoAAKostyukovaABDesign and validation of standardized clinical and functional remission criteria in schizophreniaNeuropsychiatr Dis Treat20141016718124511232
  • MurrayRMJonesPBSusserEvan OsJCannonMThe Epidemiology of SchizophreniaCambridgeCambridge University Press2003
  • AgidOKapurSArenovichTZipurskyRBDelayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejectedArch Gen Psychiatry200360121228123514662555
  • EmsleyRRabinowitzJMedoriREarly Psychosis Global Working GroupRemission in early psychosis: Rates, predictors, and clinical and functional outcome correlatesSchizophr Res2007891–312913917095194
  • DerksEMFleischhackerWWBoterHPeuskensJKahnRSEUFEST Study GroupAntipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse?J Clin Psychopharmacol201030217618020520291
  • JägerMSchmaussMLauxGEarly improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic studyEur Psychiatry200924850150619559572
  • Schennach-WolffRSeemüllerFObermeierMResponse and remission of subjective well-being in patients suffering from schizophrenia spectrum disordersEur Psychiatry201026528429220435447
  • Schennach-WolffRJägerMObermeierMQuality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?World J Biol Psychiatry201011572973820380620
  • Schennach-WolffRSeemüllerFHMayrAAn early improvement threshold to predict response and remission in first-episode schizophreniaBr J Psychiatry2010196646046620513856
  • CatonCLHasinDSShroutPEPredictors of psychosis remission in psychotic disorders that co-occur with substance useSchizopr Bull2006324618625
  • GasquetIHaroJMTcherny-LessenotSChartierFLépineJPRemission in the outpatient care of schizophrenia: 3-year results from the Schizophrenia Outpatients Health Outcomes (SOHO) study in FranceEur Psychiatry200823749149618573640
  • NovickDHaroJMSuarezDLambertMLépineJPNaberDSymptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO studyPsychopharmacology (Berl)200719141015102217310386
  • LambertMSchimmelmannBGNaberDPrediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2,960 patients with schizophreniaJ Clin Psychiatry200667111690169717196047
  • RobinsonDGWoernerMGMcMenimanMMendelowitzABilderRMSymptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorderAm J Psychiatry2004161347347914992973
  • BrekkeJKayDDLeeKSGreenMFBiosocial pathways to functional outcome in schizophreniaSchizophr Res2005802–321322516137859
  • American Psychiatric Association (APA)Diagnostic and Statistical Manual of Mental Disorders: Fourth EditionWashington DCAPA1994
  • KaySRFiszbeinAVital-HerneMFuentesLSThe Positive and Negative Syndrome Scale – Spanish adaptationJ Nerv Ment Dis199017885105172380697
  • FresánADe la Fuente-SandovalCLoyzagaCA forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patientsSchizophr Res2005722–312312915560957
  • LindenmayerJPGrochowskiSHymanRBFive factor model of schizophrenia: replication across samplesSchizophr Res19951432292347766534
  • van der GaagMCuijpersAHoffmanTThe five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutionsSchizophr Res2006851–327327916730430
  • AleniusMHammarlund-UdenaesMHartvigPLindströmLKnowledge and insight in relation to functional remission in patients with long-term psychotic disordersSoc Psychiatry Psychiatr Epidemiol201045552352919626260
  • De HertMvan WinkelRWampersMKaneJvan OsJPeuskensJRemission criteria for schizophrenia: evaluation in a large naturalistic cohortSchizophr Res2007921–3687317336500
  • EberhardJLevanderSLindströmERemission in schizophrenia: analysis in a naturalistic settingCompr Psychiatry200950320020819374962
  • FervahaGAgidOTakeuchiHFoussiasGLeeJRemingtonGClinical and functional outcomes in people with schizophrenia with a high sense of well-beingJ Nerv Ment Dis2015203318719325668654
  • HelldinLKaneJMHjärthagFNorlanderTThe importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective studySchizopr Res200911516773
  • MosolovSNPotapovAVUshakovUVRemission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient populationAnn Gen Psychiatry2012111122221826
  • LeughtSEngelRRThe relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trialsNeuropharmacology2006312406412
  • LambertMDe MarinisTPfeilJNaberDSchreinerAEstablishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatmentEur Psychiatry20102522022919926263
  • SPSS Statistics [computer software]. V20Armonk NYIBM Corporation2010
  • HosmerDWLemeshowSApplied Logistic Regression2nd edNew York, NYJohn Wiley and Sons2000
  • DixonLBDickersonFBellackASSchizophrenia Patient Outcomes Research Team (PORT)The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statementsSchizophr Bull2010361487019955389
  • ValenciaMFresanAJuárezFEscamillaRSaraccoRThe beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophreniaJ Psychiatr Res201347121886189224112947
  • DahlanRMidinMSidiHRemisssion of symptoms among schizophrenia patients receiving assertive community treatment (ACT) in Malaysia: one year follow-upSains Malays2013423389397
  • VermaSSubramanianMAbdinEPoonLYChongSASymptomatic and functional remission in patients with first-episode psychosisActa Psychiatr Scand2012126428228922616617
  • HarrisonGHopperKGraigTRecovery from psychotic illness: a 15- and 25-year international follow-up studyBr J Psychiatry200117850651711388966
  • JablenskyASartoriusNErnbergGSchizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country studyPsychol Med Monogr Suppl1992201971565705
  • World Health OrganizationSchizophrenia An International Follow-up StudyChichesterJohn Wiley and Sons1979
  • MasłowskiJPathoplastic influences on symptoms of schizophrenia. A comparative study in Libya and MaltaActa Psychiatr Scand19867366186233751665